Close
Nordic 9Nordic 9

RV Invest (investor - Others)

Germany rvinvest.de
See something wrong or missing? Let us know
Offices:Ravensburg

RVI is a VC fund of Vetter Pharma family office

Average round investment:16.15M USD
Average number per year:1.0
Distribution: 2025 (1)2024 (1)2023 (1)
Portfolio companies: Germany Akribion TherapeuticsSweden Asgard TherapeuticsUnited Kingdom Valink Therapeutics
Mostly invests in: Germany Germany (1) Biotech (3)

3 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to RV Invest

Name Criteria
United States Chris Gibson
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Software Services, AI (big data), Pharma
  • Similar business models: B2B, SAAS
  • Common investees countries: Germany
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Tola Capital
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Software Services, AI (big data), Pharma
  • Similar business models: B2B, SAAS
  • Common investees countries: Germany
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany Roman Schumacher
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Software Services, AI (big data)
  • Similar business models: B2B, SAAS
  • Common investees countries: Germany, United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Accomplice
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Software Services, AI (big data)
  • Similar business models: B2B, SAAS
  • Common investees countries: Sweden, United Kingdom
  • Average number of deals per year: 1.1
  • Active last 12 months: Yes
United States Amino Capital
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Software Services, AI (big data)
  • Similar business models: B2B, SAAS
  • Common investees countries: Sweden, United Kingdom
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
United Kingdom Jim O’Neill
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Software Services, AI (big data), Pharma
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Germany Wessel Management
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Software Services, AI (big data)
  • Similar business models: B2B, SAAS
  • Common investees countries: Germany
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
United States TransLink Capital
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Software Services, AI (big data)
  • Similar business models: B2B, SAAS
  • Common investees countries: Germany, United Kingdom
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
United States DRW Venture Capital
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Software Services, Pharma
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Cyprus 33East
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Software Services, AI (big data)
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Top